AAL vs ISPR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

AAL

38.8
AI Score
VS
AAL Wins

ISPR

37.3
AI Score

Investment Advisor Scores

AAL

39score
Recommendation
SELL

ISPR

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAL ISPR Winner
Revenue 46.98B 27.54M AAL
Net Income -580.00M -6.44M ISPR
Net Margin -1.2% -23.4% AAL
Operating Income 521.00M -6.15M AAL
ROE 13.7% 18.5% ISPR
ROA -0.9% -12.2% AAL
Total Assets 65.02B 52.82M AAL
Cash 1.12B 15.64M AAL
Current Ratio 0.53 1.01 ISPR

Relative Price Performance (Last 90 Days)

AAL 1M: +12.9% · 3M: -10.2% ISPR 1M: +24.3% · 3M: +12.3%

Current Technical Phase

AAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.2 · Price: $13.31

ISPR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.0 · Price: $1.74

Fundamentals Snapshot

Metric AAL ISPR
Market Cap — —
Forward P/E 14.1 19.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.2% 0.3%
Gross Margin 0.2% 0.1%
Operating Margin 0.0% -0.5%
EPS -0.73 -0.58
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AAL is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.